1,118
Views
48
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder

, , , , &
Pages 904-913 | Received 28 Dec 2009, Accepted 21 Apr 2010, Published online: 05 Jul 2010

References

  • American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: American Psychiatric Press.
  • Bandelow B. 1995. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10(2):73–81.
  • Bandelow B, Seidler-Brandler U, Becker A, Wedekind D, Rüther E. 2007. Meta–analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry 8(3):175–187.
  • Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C, . 2008. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9(4):248–312.
  • Banner CN, Meadows WM. 1983. Examination of the effectiveness of various treatment techniques for reducing tension. Br J Clin Psychol 22(Pt 3):183–193.
  • Barlow D, Craske M, Cerny J, Klosko J. 1989. Behavioral treatment of panic disorder. Behav Ther 20:261–282.
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 41:561–571.
  • Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897.
  • Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, . 1999. Effects of exercise training on older patients with major depression. Arch Intern Med 159(19):2349–2356.
  • Broocks A, Schweiger U, Pirke KM. 1991. The influence of semistarvation-induced hyperactivity on hypothalamic serotonin metabolism. Physiol Behav 50(2):385–388.
  • Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, . 1998. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 155(5):603–609.
  • Broocks A, Meyer T, George A, Hillmer-Vogel U, Meyer D, Bandelow B, . 1999. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Neuropsychopharmacology 20(2):150–161.
  • Broocks A, Bandelow B, George A, Jestrabeck C, Opitz M, Bartmann U, . 2000. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder. Int Clin Psychopharmacol 15(3):153–161.
  • Broocks A, Meyer T, Opitz M, Bartmann U, Hillmer-Vogel U, George A, . 2003. 5-HT(1A) responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo. Eur Neuropsychopharmacol 13(3):153–164.
  • Doyne EJ, Ossip-Klein DJ, Bowman ED, Osborn KM, McDougall-Wilson IB, Neimeyer RA. 1987. Running versus weight lifting in the treatment of depression. J Consult Clin Psychol 55(5):748–754.
  • Gent S, Corbett K, Anyad AM, Wilson J, Artchisai S. 1995. A comparison method of predicting maximum oxygen. Br J Sports Med 29(3):147–152.
  • Goldfarb AH, Jamurtas AZ. 1997. Beta-endorphin response to exercise. An update. Sports Med 24(1):8–16.
  • Greist JH, Klein MH, Eischens RR, Faris J, Gurman AS, Morgan WP. 1979. Running as treatment for depression. Compr Psychiatry 20(1):41–54.
  • Guy W. 1976. Clinical Global Impression Scale (CGI). ECDEU Assessment Manual for Psychopharmacology. Washington, D.C., National Institute of Mental Health-US Dept of Health, Education, and Welfare publication (ADM). 76–338.
  • Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32:50–55.
  • Janal MN, Colt EWD, Clark WC, Glusman M. 1984. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain 19:13–25.
  • Kanji N, White A, Ernst E. 2006. Autogenic training to reduce anxiety in nursing students: randomized controlled trial. J Adv Nurs 53(6):729–735.
  • Kröner B, Frieg H, Niewendiek U. 1982. [Use of various programs of autogenic training in test anxiety]. Z Klin Psychol Psychother 30(3):254–266.
  • Lehrer PM, Atthowe JM, Weber ESP. 1980. Effects of progressive relaxation and autogenic training of anxiety and physiological measures with some data on hypnotizability. McGuigan FJ, Simme WE, Wallace JM. Stress and tension control. New York: Plenum Press. 171–184.
  • Markoff RA, Ryan P, Young T. 1982. Endorphins and mood changes in long-distance running. Med Sci Sports Exerc 14(1):11–15.
  • Marks I. 1999. Treatment of panic disorder [letter]. Am J Psychiatry 156(7):1129–1130.
  • Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E, et al. 1983. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 40(2):153–162.
  • Martinsen EW, Medhus A, Sandvik L. 1985. Effects of aerobic exercise on depression: a controlled study. Br Med J 291:109–113.
  • Martinsen EW, Strand J, Paulsson G, Kaggestad J. 1989. Physical fitness level in patients with anxiety and depressive disorders. Int J Sports Med 10(1):58–61.
  • McCann IL, Holmes DS. 1984. Influence of aerobic exercise on depression. J Pers Soc Psychol 46(5):1142–1147.
  • Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, . 2007. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 164(2):265–272.
  • Miyakoda H, Kitamura H, Kinugawa T, Saito M, Kotake H, Mashiba H. 1990. Cardiac neurosis: exercise tolerance and the role of sympathetic activity. Jpn J Med 29(5):493–499.
  • Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389.
  • Pappas GP, Golin S, Meyer DL. 1990. Reducing symptoms of depression with exercise. Psychosomatics 31(1):112–113.
  • Post RM, Kotin J, Goodwin FK, Gordon EK. 1973. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130(1):67–72.
  • Roth DL. 1989. Acute emotional and psychophysiological effects of aerobic exercise. Psychophysiol 26(5):593–602.
  • Roth WT, Telch MJ, Taylor CB, Sachitano JA, Gallen CC, Kopell ML, . 1986. Autonomic characteristics of agoraphobia with panic attacks. Biol Psychiatry 21(12):1133–1154.
  • Sakai M. 1997. Application of autogenic training for anxiety disorders: a clinical study in a psychiatric setting. Fukuoka Igaku Zasshi 88(3):56–64.
  • Salkovskis PM, Jones DR, Clark DM. 1986. Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pCO2. Br J Psychiatry 148:526–532.
  • Schultz ICH. 1932. Das Autogene Training. Stuttgart: Thieme.
  • Sexton H, Maere A, Dahl NH. 1989. Exercise intensity and reduction in neurotic symptoms. A controlled follow-up study. Acta Psychiatr Scand 80(3):231–235.
  • Stetter F, Walter G, Zimmermann A, Zahres S, Straube ER. 1994. [Ambulatory short-term therapy of anxiety patients with autogenic training and hypnosis. Results of treatment and 3 months follow-up]. Psychother Psychosom Med Psychol 44(7):226–234.
  • Ströhle A, Feller C, Onken M, Godemann F, Heinz A, Dimeo F. 2005. The acute antipanic activity of aerobic exercise. Am J Psychiatry 162(12):2376–2378.
  • Ströhle A, Feller C, Strasburger CJ, Heinz A, Dimeo F. 2006. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 31(9):1127–1130.
  • Taylor CB, King R, Ehlers A, Margraf J, Clark D, Hayward C, et al. 1987. Treadmill exercise test and ambulatory measures in panic attacks. Am J Cardiol 60(18):48–52j.
  • The Declaration of Helsinki. 1982. World Med J 29(6):86–88.
  • WHO World Health Organisation. 1991. Tenth Revision of the International Classification of Diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.